Screening for malignancy for DVT
Updated: 2009-10-18 02:38:55
One of the stories in the news today is the scientific proof that some cancers can, in some circumstances, spread from a mother to her baby while in the womb.
Before we look at the research in depth, the first thing to point out is that this is extremely rare. Since 1866, there have only been [...]
Just a very quick post to bring you the news that MPs have tonight voted to put tobacco out of sight and out of mind, passing amendments to the Health Bill that will result in two things:
Tobacco will no longer be displayed at point of sale, and
Cigarette vending machines will be banned.
The complete ban on [...]
We’ve blogged here before about how difficult it is to detect and treat pancreatic cancer, and that one of the main challenges is that the disease is often diagnosed at a late stage. So it was encouraging to hear from Dr Jörg Hoheisel about his search for biomarkers that could potentially be used to detect [...]
There was a big buzz at the conference about PARP inhibitors. They’re a new class of cancer drugs currently undergoing early clinical trials. And there’s some really clever science behind them, which Kat has blogged about before.
But so far the excitement has been limited to a relatively rare group of patients with breast, ovarian or [...]
With just 24 hours’ notice, Professor Ashok Venkitaraman stepped in at the NCRI conference to deliver an enlightening talk on how chromosomes become unstable in cancer, after the planned speaker had to cancel at the last moment.
Professor Venkitaraman’s specialist field is ‘chromosome instability’ – the way the cell’s genetic information becomes more and more garbled [...]
As a nod to the NCRI Cancer Conference, this week’s Naked Scientists podcast is all about cancer, co-presented by Kat live from the conference.
As well as the latest news, the show features interviews with Cancer Research UK’s Professor Charles Coombes and Dr John Stingl, and the lowdown on proton radiotherapy from Professor Karen Kirkby.
There’s also [...]
Clinical trials play a crucial role in bringing new treatments to patients. But is there room for improvement in the way trials are run?
Emphatically yes, argued Professor Ian Tannock in a thought-provoking session at the NCRI conference this morning.
He outlines the main points of his talk in this short video:
Clinical trials compare new treatments with [...]
On Sunday, Professor Paul Workman talked about personalised medicine. And on Monday we heard more about this “unparalleled time of opportunity for cancer drug development,” from Johann de Bono of The Institute of Cancer Research.
Chairing a session called ‘Getting personal in anticancer drug development’, Professor de Bono went on to add that “the current [...]
The final session on a Sunday is never an easy slot to fill at any conference, but Professor Paul Workman kept the audience engrossed and engaged with a fascinating talk about ‘drugging the cancer genome to personalise cancer medicine’ – a subject we’ve written about previously.
Cancer Research UK has supported Professor Workman’s work at The [...]